Biotech

Latest Articles

Cassava pays $40M over supposedly misleading Alzheimer's improve

.Cassava Sciences has actually consented to pay $40 million to fix an inspection right into claims i...

Merck bags choices on Evaxion's AI-designed vaccine prospects

.Merck &amp Co. has grabbed choices on 2 Evaxion Biotech vaccination candidates, paying out $3.2 tho...

Enanta's RSV antiviral crushes virus-like bunch in challenge research study

.Enanta Pharmaceuticals has connected its respiratory syncytial infection (RSV) antiviral to conside...

Biogen containers SAGE-324 partnership after vital shake stop working

.Biogen has conducted the final rites to its own cooperation along with Sage Therapeutics on SAGE-32...

AbbVie Parkinson's medicine from $8.7 B Cerevel acquistion credit ratings

.On the exact same time that some Parkinson's disease drugs are being actually disputed, AbbVie has ...

Arch finalizes $3B-plus fund to promote biopharma startups

.On the heels of a $3 billion fund from Bain Resources Lifestyle Sciences, Arch Venture Allies is ac...

Orion to use Aitia's 'digital twins' to discover new cancer medicines

.Finnish biotech Orion has actually spied possible in Aitia's "electronic twin" technology to develo...

Windtree's shock med brings up high blood pressure in newest period 2 gain

.While Windtree Therapies has actually had a hard time to grow the financial origins needed to survi...

2 cancer biotechs combine, generating worldwide impact

.OncoC4 is taking AcroImmune-- and its internal scientific production functionalities-- under its ow...

Amgen documents first phase 3 gain for $400M eczema medication

.Amgen has discussed (PDF) the 1st phase 3 data on its own $400 million dermatitis medicine, linking...

Biogen, UCB record period 3 lupus gain after stopping working earlier test

.Biogen as well as UCB's gamble on developing right into period 3 on the back of an unsuccessful res...

Aptadir really hopes brand new RNA inhibitors can turn around tricky cancers cells

.Italian biotech Aptadir Therapies has actually introduced along with the guarantee that its own pip...

Wave surfs DMD results to regulators' doors, delivering stock up

.Surge Lifestyle Sciences has actually satisfied its own target in a Duchenne muscular dystrophy (DM...

Sanofi picks new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma fold, using ...

Achilles droplets tissue treatment course, prepares for cutbacks after overlooking 'industrial feasibility' goals

.Achilles Rehabs has actually shreded its method. The British biotech is stopping work on its own cl...

Aligos trumpets phase 2 MASH win, reducing liver fat around 46%

.Aligos Rehabs is declaring a midstage gain in metabolic-dysfunction linked steatohepatitis (MASH) a...

Basilea scores $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work developing brand new antifungals has actually gotten a significant inc...

Capricor offers Europe civil rights to late-stage DMD therapy for $35M

.Having presently scooped up the united state legal rights to Capricor Therapies' late-stage Duchenn...

FDA scraps adcomm for Applied's unusual ailment medication

.After pushing the choice meeting for Applied Rehabs' metabolic problem medication govorestat, the F...

Novo inks $600M NanoVation offer to analyze hereditary medications ex-liver

.Novo Nordisk is actually proceeding its push right into hereditary medicines, agreeing to pay NanoV...